CH487897A - Verfahren zur Herstellung eines wasserlöslichen Komplexes des 8-Hydroxy-chinolin-(-sulfonates von 1,5-Dimethyl-4-dimethyl-amino-2-phenyl-3-isopyrazolon - Google Patents

Verfahren zur Herstellung eines wasserlöslichen Komplexes des 8-Hydroxy-chinolin-(-sulfonates von 1,5-Dimethyl-4-dimethyl-amino-2-phenyl-3-isopyrazolon

Info

Publication number
CH487897A
CH487897A CH701567A CH701567A CH487897A CH 487897 A CH487897 A CH 487897A CH 701567 A CH701567 A CH 701567A CH 701567 A CH701567 A CH 701567A CH 487897 A CH487897 A CH 487897A
Authority
CH
Switzerland
Prior art keywords
dimethyl
isopyrazolone
quinoline
sulfonate
hydroxy
Prior art date
Application number
CH701567A
Other languages
English (en)
Inventor
Beffa Alberto Della
Mambrino Del Saz Franco
Borsa Giovanni
Original Assignee
Causyth Chim Farm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE629650D priority Critical patent/BE629650A/xx
Priority to FR940455A priority patent/FR2910M/fr
Priority to GB29664/64A priority patent/GB1072359A/en
Application filed by Causyth Chim Farm filed Critical Causyth Chim Farm
Priority to CH701567A priority patent/CH487897A/de
Publication of CH487897A publication Critical patent/CH487897A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH701567A 1967-05-18 1967-05-18 Verfahren zur Herstellung eines wasserlöslichen Komplexes des 8-Hydroxy-chinolin-(-sulfonates von 1,5-Dimethyl-4-dimethyl-amino-2-phenyl-3-isopyrazolon CH487897A (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
BE629650D BE629650A (de) 1967-05-18
FR940455A FR2910M (fr) 1967-05-18 1963-07-05 Nouvelle forme injectable d'ortho-hydroxyquinoléine sulfonate de phényl-1 diméthyl-2,3 diméthylamino-4 pyrazolone-5 utile dans la thérapie anti-grippale et antirhumastimale.
GB29664/64A GB1072359A (en) 1967-05-18 1964-07-23 Pyrazolone derivatives and pharmaceutical compositions containing them
CH701567A CH487897A (de) 1967-05-18 1967-05-18 Verfahren zur Herstellung eines wasserlöslichen Komplexes des 8-Hydroxy-chinolin-(-sulfonates von 1,5-Dimethyl-4-dimethyl-amino-2-phenyl-3-isopyrazolon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH701567A CH487897A (de) 1967-05-18 1967-05-18 Verfahren zur Herstellung eines wasserlöslichen Komplexes des 8-Hydroxy-chinolin-(-sulfonates von 1,5-Dimethyl-4-dimethyl-amino-2-phenyl-3-isopyrazolon

Publications (1)

Publication Number Publication Date
CH487897A true CH487897A (de) 1970-03-31

Family

ID=4318592

Family Applications (1)

Application Number Title Priority Date Filing Date
CH701567A CH487897A (de) 1967-05-18 1967-05-18 Verfahren zur Herstellung eines wasserlöslichen Komplexes des 8-Hydroxy-chinolin-(-sulfonates von 1,5-Dimethyl-4-dimethyl-amino-2-phenyl-3-isopyrazolon

Country Status (4)

Country Link
BE (1) BE629650A (de)
CH (1) CH487897A (de)
FR (1) FR2910M (de)
GB (1) GB1072359A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3217315C2 (de) * 1982-05-08 1986-05-22 Gödecke AG, 1000 Berlin Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten
DE3437232A1 (de) * 1984-10-10 1986-04-17 Mack Chem Pharm Stabilisierte injektionsloesungen von piroxicam
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale

Also Published As

Publication number Publication date
FR2910M (fr) 1964-11-09
GB1072359A (en) 1967-06-14
BE629650A (de) 1900-01-01

Similar Documents

Publication Publication Date Title
CH481110A (de) Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
CH480410A (de) Verfahren zur Herstellung von wasserlöslichen Azopyrimidinfarbstoffen
CH518953A (de) Verfahren zur Herstellung von 2-Methyl-3-carbonsäure-amidochinoxalin-di-N-oxiden-(1,4)
CH512499A (de) Verfahren zur Herstellung von 2-Halogenmethyl-3-carbonsäureamido-chinoxalin-di-N-oxiden-(1,4)
CH523264A (de) Verfahren zur Herstellung von 2,4 Benzdiazepinen
CH506537A (de) Verfahren zur Herstellung von 2-Isothiuroniummethyl-3-carbonsäureamido-chinoxalin-di-N-oxid(1,4)-halogeniden
CH487897A (de) Verfahren zur Herstellung eines wasserlöslichen Komplexes des 8-Hydroxy-chinolin-(-sulfonates von 1,5-Dimethyl-4-dimethyl-amino-2-phenyl-3-isopyrazolon
CH521422A (de) Verfahren zur Herstellung von wasserlöslichen Azopyrimidinfarbstoffen
CH465095A (de) Verfahren zur Herstellung eines wasserlöslichen 1:1 Azofarbstoff-Chrom-Komplexes
CH471782A (de) Verfahren zur Herstellung eines neuen, substituierten 2,3-Pyridindiols
CH495999A (de) Verfahren zur Herstellung von 1,4,9,10-Tetrahydro-benzo-(5,6)cycloheptal(1,2-d)imidazol-4-onen
CH493552A (de) Verfahren zur Herstellung von 3-Oxo-5-chlor-1,2,4-thiadiazolinium-Salzen
CH524563A (de) Verfahren zur Herstellung von 3,5-Diniederalkoxy-homophthalsäuren
CH479544A (de) Verfahren zur Herstellung von 2,5-Diamino-3,6-dihalogen-p-benzochinonen
CH482684A (de) Verfahren zur Herstellung eines neuen Herbicids
AT281318B (de) Verfahren zur Herstellung von 3,5-Dioxo-4,5-seco-13β-R-17α-äthinyl-17β-hydroxygona-9-enen
CH466250A (de) Verfahren zur Herstellung von a,a,a',a'-Tetramethyl-xylylen-dicarbinolen
AT298686B (de) Verfahren zur Herstellung von 6,7-Benzomorphan-Derivaten
CH484932A (de) Verfahren zur Herstellung von 1,2-Benzisothiazolen
CH507891A (de) Verfahren zur Herstellung von Derivaten des 3,7-Dimethyl-2,7-3ctadien-1-al
AT281022B (de) Verfahren zur Herstellung von 1-n-Butyl-2',6'-pipecoloxylidid
AT291967B (de) Verfahren zur Herstellung von neuen N-Phenyl-N-2-fluor-1,1,2,2,-tetrachloräthylsulfenyl-sulfamiden
CH516566A (de) Verfahren zur Herstellung von 2,4-Dihydroxy-5-aminomethyl-6-methylpyrimidinen
CH487822A (de) Verfahren zur Herstellung von 1,4-Dihalogenanthrachinonen
CH507210A (de) Verfahren zur Herstellung von 2,3-Dihalogenacrylaniliden

Legal Events

Date Code Title Description
PL Patent ceased